Embolization Coils Market Is Projected To Exhibit A Compound Annual Growth Rate At A CAGR Of 5% BY 2032

With a predicted compound annual growth rate (CAGR) of 5% from 2022 to 2032, the global market for embolization coils is anticipated to exceed an amazing valuation of US$ 1,200 Million in 2022. Heart and brain aneurysms, as well as other blood-related disorders, are treated with embolization coils.

They are used as an alternative to surgical embolization to cut the blood supply to the tumor. It is used to treat various types of diseases, such as liver cancer, kidney cancer, aortic artery disorders, neuroendocrine tumors, and peripheral vascular diseases.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:https://www.factmr.com/connectus/sample?flag=S&rep_id=8070?pj

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲

• The global Embolization Coils market is expected to garner a market value of US$ 1,200 Million
• Market is projected to exhibit a compound annual growth rate (CAGR) of 5% from 2022 to 2032.
• The Europe embolization coils market size is anticipated to register commendable growth, with the United Kingdom acquiring a major share.
• North America was the leading regional segment in terms of revenue and market share.
• Based on type, the detachable coil segment holds a larger market share.
• Based on application, In 2022, the neurology segment holds the largest share of the market.
• Based on end users, the hospital segment holds the largest share of the market.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

1. North America: North America is anticipated to hold a significant share in the embolization coils market. This can be attributed to factors such as the high prevalence of vascular diseases, well-established healthcare infrastructure, and a strong presence of key market players in the region. Moreover, the increasing adoption of minimally invasive procedures and favorable reimbursement policies further contribute to market growth in North America.

2. Europe: Europe is another prominent market for embolization coils. The region benefits from advanced healthcare systems, skilled medical professionals, and a growing geriatric population. Countries such as Germany, the UK, and France are expected to contribute significantly to the market growth. Additionally, increasing awareness about minimally invasive treatment options and rising investments in healthcare infrastructure propel the demand for embolization coils in Europe.

3. Asia Pacific: The Asia Pacific region is projected to witness substantial growth in the embolization coils market. Factors such as a large population base, increasing disposable income, and the rising prevalence of vascular diseases drive market expansion. Moreover, improving healthcare facilities, growing medical tourism, and the adoption of advanced medical technologies in countries like China, India, and Japan contribute to the market's growth potential in the region.

4. Rest of the World: The rest of the world, including regions such as Latin America, the Middle East, and Africa, is expected to experience steady growth in the embolization coils market. Factors such as the increasing healthcare expenditure, improving healthcare infrastructure, and the rising awareness about minimally invasive procedures drive market growth in these regions. However, challenges such as limited access to healthcare facilities and economic constraints may impact market growth to some extent.

𝐖𝐡𝐢𝐜𝐡 𝐚𝐫𝐞 𝐒𝐨𝐦𝐞 𝐏𝐫𝐨𝐦𝐢𝐧𝐞𝐧𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐄𝐦𝐛𝐨𝐥𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐂𝐨𝐢𝐥𝐬 𝐌𝐚𝐫𝐤𝐞𝐭?

• Increasing prevalence of vascular diseases and conditions.
• Advancements in medical imaging technologies and interventional radiology techniques.
• Growing adoption of minimally invasive procedures.
• Rising geriatric population.
• Favorable reimbursement policies.
• Technological advancements in embolization coil design and materials.
• Expansion of healthcare infrastructure in developing economies.
• Rising awareness about the benefits of embolization procedures.
• Growing demand for effective and safe treatment options.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐨𝐧:

• In July 2021, Terumo Medical Corporation (TMC) introduced its AZUR Vascular Plug, the first and only plug compatible with a microcatheter to occlude arteries up to 8mm in diameter. The newest addition to Terumo's robust embolization portfolio is indicated for use to reduce or block the rate of blood flow in arteries of the peripheral vasculature.

• In April 2021, the US Food and Drug Administration (FDA) approved the Pipeline Flex Embolization Device with Shield Technology of Medtronic PLC, which was indicated primarily for brain aneurysms. Shield Technology enhances the flow diverter device by decreasing thrombogenicity caused due to the material.

• In August 2022, MicroPort Scientific Corporation announced that it has received approval from the Colombian Institute for Drug and Food Surveillance (INVIMA) for its MinosTM Abdominal Aortic Stent-Graft and Delivery System. As a brand new abdominal aortic stent-graft system independently developed by Endovastec™, the Minos™ System is designed for the interventional therapy of infrarenal aortic aneurysms. It is the first domestically made stent-graft system which features an ultra-low profile delivery system with an outer diameter of 14F.

• Boston Scientific Corporation offers the Pushable 0.018" and 0.035" Embolization Coils. These coils offer successful embolization through a systematic approach including guidewires, catheters, coils, and/or embolic materials. The VortX 18 and 35 Vascular Occlusion Coils are designed with a proprietary conical shape and an apex-first deployment. VortX Coils are pushable coils designed to provide compact, complete vascular occlusion and efficient embolization.

𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝

• Terumo Corporation
• Medtronic plc
• Boston Scientific Corporation
• Stryker Corporation
• KANEKA CORPORATION
• MicroPort Scientific Corporation
• Penumbra, Inc.
• Cook Medical LLC
• Johnson & Johnson Services, Inc.
• Shape Memory Medical INC

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐄𝐦𝐛𝐨𝐥𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐂𝐨𝐢𝐥𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐒𝐮𝐫𝐯𝐞𝐲

• By Type :

• Detachable Coil
• Pushable Coil

• By Application :

• Neurology
• Cardiology
• Urology
• Oncology
• Peripheral Vascular Disease
• Other

• By End-user :

• Hospitals
• Cardio Center
• Ambulatory Center
• Others

• By Material :

• Platinum
• Platinum & Hydrogel
• Platinum Tungsten Alloy

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬:https://www.factmr.com/connectus/sample?flag=RC&rep_id=8070?PJ

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

Fact.MR is a market research and consulting firm with deep expertise in emerging market intelligence. Ranging from Automotive and Industry 4.0 to Healthcare, Technology, Chemicals, Materials and even the most niche categories.

This release was published on openPR.